The rapid growth of AI agents has made them one of the fastest-scaling software categories by 2026, with the global market expanding from $5.25 billion
At the J.P. Morgan Healthcare Conference, Hippocratic AI announced a strategic expansion into the life sciences sector through the acquisition of Grove AI, a company
In a year marked by sustained momentum in large-scale AI funding, Hippocratic AI stood out among U.S.-based startups raising $100 million or more in 2025.
On January 8, 2026, Hippocratic AI announced a collaboration with Huron Consulting Group to deploy generative AI healthcare agents across Huron-led transformation initiatives serving more
On January 8, 2026, Hippocratic AI announced a collaboration with Huron Consulting Group to deploy safety-focused generative AI healthcare agents across Huron-led healthcare transformation programs.
Hippocratic AI announced a collaboration with Huron Consulting Group focused on applying generative AI to healthcare operations and patient support, including care navigation after discharge,
At the J.P. Morgan Healthcare Conference, Hippocratic AI announced an expansion into the life sciences sector through the acquisition of Grove AI. Grove AI’s technology
Hippocratic AI expanded into life sciences through the acquisition of Grove AI, adding clinical trial–focused agentic AI to its existing patient-facing healthcare platform. The move
At a Boston Consulting Group event held alongside the JPM Healthcare Conference, Hippocratic AI was highlighted as an example of how AI can address structural
Hippocratic AI expanded its life sciences business through the acquisition of Grove AI, the launch of a dedicated Life Sciences Division, and the formation of
Hippocratic AI expanded into the life sciences sector through the acquisition of Grove AI, adding agentic AI capabilities for pharmaceutical research, development, and clinical trial
Hippocratic AI reported rapid expansion across providers, payors, life sciences, and the public sector following its $126 million Series C round at a $3.5 billion
Hippocratic AI announced a global collaboration with Boston Consulting Group to deploy generative AI healthcare agents across biopharma and medtech organizations. The partnership combines Hippocratic
Hippocratic AI expanded its life sciences footprint with the acquisition of Grove AI, adding agentic AI capabilities for pharmaceutical R&D and clinical trial operations to
Hippocratic AI is expanding its presence in life sciences by acquiring Grove AI, a startup focused on agentic AI for pharma R&D and clinical trial
Hippocratic AI has entered a collaboration with Huron Consulting Group to integrate generative AI healthcare agents into Huron-led healthcare transformation programs. The initiative is designed
Hippocratic AI has formed a partnership with Boston Consulting Group to support the biopharma and medtech industries in implementing generative AI healthcare agents at scale.
Hippocratic AI has entered a strategic collaboration with Huron Consulting Group to help healthcare organizations deploy safe, scalable generative AI agents that improve access, continuity
Indonesia’s sovereign AI strategy is positioning healthcare as a priority area for agentic systems that can operate at national scale while respecting local data control
Nvidia has steadily expanded its influence across the AI sector through a series of strategic investments between 2023 and 2024, reinforcing its role as both